A detailed history of Sovereign Financial Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Sovereign Financial Group, Inc. holds 4,299 shares of JNJ stock, worth $666,516. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,299
Previous 4,310 0.26%
Holding current value
$666,516
Previous $629,000 10.65%
% of portfolio
0.17%
Previous 0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$145.48 - $167.38 $1,600 - $1,841
-11 Reduced 0.26%
4,299 $696,000
Q2 2024

Jul 15, 2024

SELL
$144.38 - $157.78 $23,100 - $25,244
-160 Reduced 3.58%
4,310 $629,000
Q1 2024

Apr 15, 2024

SELL
$155.22 - $162.74 $4,190 - $4,393
-27 Reduced 0.6%
4,470 $707,000
Q4 2023

Feb 06, 2024

BUY
$145.6 - $158.88 $26,790 - $29,233
184 Added 4.27%
4,497 $704,000
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $118,370 - $132,604
-760 Reduced 14.98%
4,313 $671,000
Q2 2023

Jul 31, 2023

BUY
$154.35 - $166.11 $87,670 - $94,350
568 Added 12.61%
5,073 $839,000
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $1,812 - $2,163
12 Added 0.27%
4,505 $698,000
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $126,077 - $141,494
787 Added 21.24%
4,493 $793,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $6,130 - $6,821
38 Added 1.04%
3,706 $605,000
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $12,277 - $13,578
73 Added 2.03%
3,668 $651,000
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $22,455 - $25,501
142 Added 4.11%
3,595 $637,000
Q4 2021

Feb 15, 2022

BUY
$155.93 - $173.01 $129,577 - $143,771
831 Added 31.69%
3,453 $591,000
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $210,434 - $233,849
-1,303 Reduced 33.2%
2,622 $423,000
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $103,169 - $114,903
674 Added 20.73%
3,925 $645,000
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $445,744 - $511,642
3,251 New
3,251 $512,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sovereign Financial Group, Inc. Portfolio

Follow Sovereign Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sovereign Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sovereign Financial Group, Inc. with notifications on news.